Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide¹. At Boehringer Ingelheim we address unmet medical need by providing innovative treatments that improve the care of patients suffering from a range of cardiovascular conditions including irregular heartbeat (atrial fibrillation), stroke, blood clots in deep veins or lungs (deep vein thrombosis or pulmonary embolism), high blood pressure (hypertension) or heart attack (myocardial infarction).

¹ Vilahur G et al. Eur Heart J Suppl 2014; 16(Suppl_A): A7-A11.